Overview
ATTO market data
Price History
ATTO price chart
Valuation & Profitability
- P/E (TTM)
- 0.00 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$6.61 Diluted earnings per share over the trailing twelve months.
- Beta
- 19,555.53 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.0% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 0.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $18.50 – $22.79 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.5K · P/B 1.70 · P/S 0.00.
Company News
8-K filing — Attovia Therapeutics, Inc. (ATTO)SEC EDGAR · Aug 6, 2026, 8:12 PM
CORRECTION: Attovia Therapeutics IPO Shares Open For Trade At $21/Share; IPO Priced At $17/Share On 17M SharesBenzinga · Aug 5, 2026, 4:22 PM
Attovia Therapeutics IPO Shares Open For Trade At $17/Share; IPO Priced At $17/Share On 17M SharesBenzinga · Aug 5, 2026, 4:21 PM
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO security released for quotationBenzinga · Aug 5, 2026, 2:10 PM
Reported Earlier, Attovia Therapeutics Prices Upsized Initial Public Offering Of 17M Shares At $17.00 Per Share, Raising $289.0MBenzinga · Aug 5, 2026, 6:54 AM